System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Tobias Keck is an expert in Surgery at University Hospital Schleswig-Holstein (Germany). As of October 2026, ScienceLeadR ranks Tobias Keck in the top 1% of experts worldwide for Pancreatic Diseases. Tobias Keck has authored 600 publications, the most recent in 2026, and is an investigator in 10 clinical trials, 1 of them ongoing. SLR score: 1,611 (community average: 125). How the SLR is computed.

LeadR Profile

Tobias Keck University Hospital Schleswig-Holstein Germany
1 611 ScienceLeadR Reputation 1611

Unlock

Register Login
Network Map

Surgery

Subspecialties: Gastroenterology - Oncology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026
Source: PubMed

University Hospital Schleswig-Holstein

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 600

Citations

Citations: 11 401 1st author: 35 Last author: 107 Unique author: 26

Main journals

Zentralbl Chir 52
Z Gastroenterol 50
Gastroenterology 41
HPB (Oxford) 41
Pancreatology 29

Best Journals

J Clin Oncol 5
Gastroenterology 3
Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma.
PMID 42624885 — pharmaceutical preparations, neoplasms, adenocarcinoma, therapeutics, tissues		NPJ Precis Oncol20260
Cost-effectiveness Analysis of Robotic Versus Open Pancreatoduodenectomy (DIPLOMA-2): A Multicenter International Randomized Trial.
PMID 42606345 — quality of life, hospital costs, probability, pancreaticoduodenectomy, quality-adjusted life years, general surgery		Ann Surg20260
Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice?
PMID 42588642 — pancreatic neoplasms, neoplasms, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, demography, chemotherapy		Cancers (Basel)20260
Robot-assisted versus open pancreatoduodenectomy for cancer in the pancreatic head (DIPLOMA-2x2): study protocol for an international multicentre patient- and assessor-blinded randomized controlled non-inferiority trial.
PMID 42464359 — safety, pancreaticoduodenectomy, neoplasms, recycling, therapeutics		Trials20261
[Digital Twins in Surgery].
PMID 42442699 — general surgery, digital twin		Zentralbl Chir20261

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 6
Phase 3 4

By status:

Completed 6
Unknown 2
Active not recruiting 1
Recruiting 1

By type:

Interventional 5
Observational 5

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Intensified treatment in patients with oligometastatic pancreatic cancer multimodal surgical treatment versus systemic chemotherapy alone a randomized controlled trial METAPANC
2023-503558-10-00 — pancreatic neoplasms, neoplasms, drug therapy, therapeutics, chemotherapy		Phase 3Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS